Olstein Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Olstein Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,750	Closed	-$3.32M	–	81
2026 Q1	$3.32M	Buy	6,750 +350	+5%	+$190K	0.72%	70
2025 Q4	$3.71M	Sell	6,400 -1,600	-20%	-$905K	0.76%	68
2025 Q3	$3.88M	Hold	8,000	–	–	0.73%	68
2025 Q2	$3.24M	Buy	+8,000	New	+$3.34M	0.61%	76
2020 Q3	–	Sell	-7,000	Closed	-$2.54M	–	107
2020 Q2	$2.54M	Sell	7,000 -2,500	-26%	-$838K	0.47%	84
2020 Q1	$2.69M	Hold	9,500	–	–	0.59%	83
2019 Q4	$3.09M	Sell	9,500 -1,000	-10%	-$303K	0.48%	91
2019 Q3	$3.06M	Hold	10,500	–	–	0.48%	91
2019 Q2	$3.08M	Sell	10,500 -1,500	-13%	-$413K	0.5%	92
2019 Q1	$3.29M	Sell	12,000 -500	-4%	-$124K	0.54%	88
2018 Q4	$2.8M	Sell	12,500 -9,500	-43%	-$2.23M	0.46%	92
2018 Q3	$5.37M	Sell	22,000 -1,000	-4%	-$230K	0.72%	67
2018 Q2	$4.76M	Hold	23,000	–	–	0.63%	80
2018 Q1	$4.75M	Hold	23,000	–	–	0.6%	81
2017 Q4	$4.37M	Hold	23,000	–	–	0.56%	76
2017 Q3	$4.35M	Hold	23,000	–	–	0.56%	81
2017 Q2	$4.01M	Buy	+23,000	New	+$3.86M	0.51%	87

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Olstein Capital Management's TMO Position: Q2 2026 in Review

Olstein Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 6,750 shares — an estimated $3.32M sold.

Olstein Capital Management first reported a position in TMO in Q2 2017 and held it in 17 quarters. The position peaked at $5.37M in Q3 2018. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Olstein Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Olstein Capital Management sold 6,750 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.32M.
Olstein Capital Management first reported a position in Thermo Fisher Scientific in Q2 2017 and held it in 17 quarters.
Olstein Capital Management's Thermo Fisher Scientific position peaked at $5.37M in Q3 2018.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Olstein Capital Management's 13F filing for Q2 2026.